Masimo Long Term Debt 2010-2025 | MASI

Masimo long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • Masimo long term debt for the quarter ending June 30, 2025 was $0.599B, a 19.8% decline year-over-year.
  • Masimo long term debt for 2024 was $0.728B, a 16.5% decline from 2023.
  • Masimo long term debt for 2023 was $0.872B, a 7.42% decline from 2022.
  • Masimo long term debt for 2022 was $0.942B, a 0% decline from 2021.
Masimo Annual Long Term Debt
(Millions of US $)
2024 $728
2023 $872
2022 $942
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $185
2014 $125
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Masimo Quarterly Long Term Debt
(Millions of US $)
2025-06-30 $599
2025-03-31 $636
2024-12-31 $714
2024-09-30 $733
2024-06-30 $747
2024-03-31 $841
2023-12-31 $872
2023-09-30 $910
2023-06-30 $889
2023-03-31 $898
2022-12-31 $942
2022-09-30 $951
2022-06-30 $922
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30 $153
2016-06-30 $175
2016-03-31 $225
2015-12-31 $185
2015-09-30 $190
2015-06-30 $178
2015-03-31 $125
2014-12-31 $125
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.074B $2.094B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $188.802B 22.84
Intuitive Surgical (ISRG) United States $170.692B 70.75
IDEXX Laboratories (IDXX) United States $51.647B 53.75
Edwards Lifesciences (EW) United States $48.042B 31.84
Alcon (ALC) Switzerland $40.456B 27.16
IQVIA Holdings (IQV) United States $32.496B 18.36
DexCom (DXCM) United States $32.259B 48.39
Mettler-Toledo (MTD) United States $27.221B 32.31
STERIS (STE) Ireland $24.807B 26.40
Waters (WAT) United States $17.988B 24.71
SONOVA HOLDING (SONVY) Switzerland $17.319B 0.00
Hologic (HOLX) United States $15.182B 16.45
Penumbra (PEN) United States $10.325B 75.42
Globus Medical (GMED) United States $8.444B 19.48
Sysmex ADR (SSMXY) Japan $8.410B 26.72
Teleflex (TFX) United States $5.719B 9.23
Glaukos (GKOS) United States $5.400B 0.00
TransMedics (TMDX) United States $4.086B 62.10
Integer Holdings (ITGR) United States $3.874B 19.33
LivaNova (LIVN) United Kingdom $3.052B 17.47
Veracyte (VCYT) United States $2.439B 33.70
Alphatec Holdings (ATEC) United States $2.388B 0.00
PROCEPT BioRobotics (PRCT) United States $2.294B 0.00
Artivion (AORT) United States $2.115B 106.74
Elekta AB (EKTAY) Sweden $1.924B 18.00
Nihon Kohden (NHNKY) Japan $1.914B 22.85
Integra LifeSciences Holdings (IART) United States $1.158B 6.63
Pulse Biosciences (PLSE) United States $1.147B 0.00
OPKO Health (OPK) United States $1.119B 0.00
IRadimed (IRMD) United States $0.924B 44.85
Tandem Diabetes Care (TNDM) United States $0.806B 0.00
AxoGen (AXGN) United States $0.748B 0.00
Beta Bionics (BBNX) United States $0.741B 0.00
SiBone (SIBN) United States $0.707B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.575B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.543B 9.60
OrthoPediatrics (KIDS) United States $0.506B 0.00
Treace Medical Concepts (TMCI) United States $0.486B 0.00
Semler Scientific (SMLR) United States $0.465B 3.74
Pacific Biosciences Of California (PACB) United States $0.415B 0.00
Mesa Laboratories (MLAB) United States $0.401B 10.20
Delcath Systems (DCTH) United States $0.389B 92.67
AngioDynamics (ANGO) United States $0.384B 0.00
RxSight (RXST) United States $0.380B 0.00
ClearPoint Neuro (CLPT) United States $0.304B 0.00
NeuroPace (NPCE) United States $0.297B 0.00
Tactile Systems Technology (TCMD) United States $0.295B 20.35
Spectral Diagnostics (EDTXF) Canada $0.289B 0.00
Alpha Tau Medical (DRTS) Israel $0.268B 0.00
908 Devices (MASS) United States $0.231B 0.00
Neuronetics (STIM) United States $0.225B 0.00
Sight Sciences (SGHT) United States $0.222B 0.00
Monogram Orthopaedics (MGRM) United States $0.221B 0.00
Inogen (INGN) United States $0.210B 0.00
CVRx (CVRX) United States $0.204B 0.00
Accuray (ARAY) United States $0.179B 0.00
Microbot Medical (MBOT) United States $0.175B 0.00
Biosig Technologies (BSGM) United States $0.163B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Anteris Technologies Global (AVR) Australia $0.150B 0.00
Rapid Micro Biosystems (RPID) United States $0.125B 0.00
Lucid Diagnostics (LUCD) United States $0.119B 0.00
Hyperfine (HYPR) United States $0.101B 0.00
Atossa Genetics (ATOS) United States $0.100B 0.00
InspireMD (NSPR) United States $0.099B 0.00
Baird Medical Investment Holdings (BDMD) $0.082B 0.00
QT Imaging Holdings (QTIH) United States $0.061B 0.00
Sensus Healthcare (SRTS) United States $0.053B 0.00
Spectral AI (MDAI) United States $0.053B 0.00
Positron (POSC) United States $0.051B 0.00
EDAP TMS S.A (EDAP) France $0.050B 0.00
WORK Medical Technology Group (WOK) China $0.044B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Precision Optics (POCI) United States $0.038B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Envoy Medical (COCH) United States $0.025B 0.00
Adagio Medical Holdings (ADGM) United States $0.020B 0.00
EnVVeno Medical (NVNO) United States $0.019B 0.00
NexGel (NXGL) United States $0.019B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Tenon Medical (TNON) United States $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.009B 0.00
Vyome Holdings (HIND) United States $0.008B 0.00
Helius Medical Technologies (HSDT) United States $0.007B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 13.54